미래에셋생명 085620

http://comp.fnguide.com/SVO2/asp/SVD_Main.asp?pGB=1&gicode=A085620&cID=&MenuYn=Y&ReportGB=&NewMenuID=101&stkGb=701

미래에셋생명(A085620) | Snapshot | 기업정보 | Company Guide

- 차별화된 컨셉은 분명한 강점 중립(신규편입) 목표주가: 5,500 원(신규편입)
  현재주가: 5,280 원 상승여력: 4.2% - SK증권 - 2024.09.24 downpdf (hankyung.com)
- 배당에 큰 변화 없을 전망 BUY TP 4,000원 (M) 현재주가 (8/24) 3,580원 상승여력 12% -
  유안타증권 - 2023.08.25 1692919599966.pdf (pstatic.net)
- 이유 있는 어닝 쇼크 투자의견 BUY (M) 목표주가 4,000원 (M) 현재주가 (2/22) 2,885원 
  상승여력 39% -  유안타증권 - 2023.02.23 analysis.downpdf (hankyung.com)
- 증시 부진으로 특별계정자산 감소 투자의견 BUY 목표주가 5,000원 (M) 주가 (5/13) 3,705원
  상승여력 35% -  유안타증권 - 2022.05.16 analysis.downpdf (hankyung.com)
- 증시 부진으로 특별계정자산 성장 둔화 투자의견 BUY 목표주가 5,000원 (M) 상승여력 22%
  현재주가 (2/18) 4,095원   -  유안타증권 - 2022.02.21 analysis.downpdf (hankyung.com)
- 자본비용 감소와 2분기 실적 개선 전망 BUY I TP(12M): 5,700원 I CP(6월17일): 4,280원 -
  하나대투 - 2021.06.18 
https://www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/06/17/210618_MLI_Update_v2.pdf
- 아쉬움은 조금 남지만 비관적인 내용 없음 BUY I TP(12M): 5,700원 I CP(3월09일): 4,105원 - 
  하나대투 - 2021.03.10
www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/03/09/210310_MLI_4Q20R_v2.pdf
- 새로운 Two-Track 전략도 긍정적으로 판단 BUY I TP(12M): 5,700원 I CP(12월22일): 3,965원 -
  하나대투 - 2020.12.23
www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2020/12/22/201223_MLI_4Q20P_0.pdf
- 2Q20E: 전년동기와 유사한 실적 예상 투자의견 BUY (M) TP 5,000원 (M) 주가 7/10 2,715원 
  상승여력 84% -   유안타증권 - 2020.07.13
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=565803
- 1Q20E: 변액 자산 감소로 컨센서스 하회 예상 투자의견 BUY (M) TP 5,000원 (M) 
  현재주가 4/10 3,850원 상승여력 30% - 유안타증권 - 2020.04.13
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=556927
- 빈 곳간을 채울 때 매수 (유지) 주가 (3월 18일) 5,250원 목표주가 6,500원 (상향) 
  상승여력 23.8% - 신한투자 - 2019.03.19 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=517518
- 배당까지 주는 변액보험 강자 Trading Buy 신규 TP 6,200원 신규 현재가(02/22) 5,060 원 -
  교보증권 - 2019.02.25
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=514726
- 본격적인 이익 개선 시작 매수 (유지) 주가 (8월 14일) 5,130원 목표주가 6,800원 (유지) 
  상승여력 32.6% -  신한투자 - 2018.08.16
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=490130
- 2Q18 Review: 보험영업손익 증가로 컨센서스 상회 Buy 유지 목표주가 (유지, 원) 6,500
  Upside / Downside (%) 26.7 현재가 (8/14, 원)  5,130 -KB증권 - 2018.08.16 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=489764
- 先 자산성장, 後 이익개선 Buy (initiate) TP 7,000 원 주가 5,200 원 - 이베스트증권 - 2018.03.05 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=467275
- 양호한 이익 증가세 시현 매수 (유지) 주가 (2 월 27 일) 5,240 원 TP 6,800 원 (유지) 
  상승여력 29.8% -  신한투자 - 2018.02.28
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=466766
- 4Q Review: 수익성을 선행하는 성장 지표의 호조 Buy 유지 TP (유지,원) 6,500  
  현재주가 (2 /27 ) 5,240 원 -   KB증권 - 2018.02.28 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=466765
- PCA 통합 원년, 개선은 지속된다  투자의견 BUY (M) TP 8,200원 (M) 주가 (2/27) 5,240원 
  상승여력 56% -  유안타증권 - 2018.02.28 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=466753
- 미래를 위한 도약을 꿈꾸다 매수 (신규) 현재주가 (2 월 19 일) 5,260 원 TP 6,800 원 (신규) 
  상승여력 29.3% -  신한투자 - 2018.02.20
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=465727
- 3Q17 Review: 기대 이상의 실적 투자의견 BUY (M) 목표주가 8,200원 (M) 
  현재주가 (11/8) 5,880원  상승여력 39% - 유안타증권 - 2017.11.09
   http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=451258